These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 7503385
21. Vigabatrin use in psychotic epileptic patients: report of a prospective pilot study. Veggiotti P, De Agostini G, Muzio C, Termine C, Baldi PL, Ferrari Ginevra O, Lanzi G. Acta Neurol Scand; 1999 Mar; 99(3):142-6. PubMed ID: 10100956 [Abstract] [Full Text] [Related]
22. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes. Bélanger S, Coulombe G, Carmant L. Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380 [Abstract] [Full Text] [Related]
23. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group. Arzimanoglou AA, Dumas C, Ghirardi L. Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252 [Abstract] [Full Text] [Related]
24. Gamma-vinyl GABA (vigabatrin) and mood disturbances. Aldenkamp AP, Vermeulen J, Mulder OG, Overweg J, Van Parys JA, Beun AM, Van 't Slot B. Epilepsia; 1994 Jun; 35(5):999-1004. PubMed ID: 7925172 [Abstract] [Full Text] [Related]
25. Vigabatrin in childhood epilepsy: a 5-year follow-up study. Uldall P, Alving J, Gram L, Høgenhaven H. Neuropediatrics; 1995 Oct; 26(5):253-6. PubMed ID: 8552215 [Abstract] [Full Text] [Related]
26. [Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice]. van der Zwan A, van der Zwan A. Ned Tijdschr Geneeskd; 1994 Sep 10; 138(37):1859-63. PubMed ID: 7935922 [Abstract] [Full Text] [Related]
27. Vigabatrin in childhood epilepsy. Dulac O, Chiron C, Luna D, Cusmai R, Pajot N, Beaumont D, Mondragon S. J Child Neurol; 1991 Sep 10; Suppl 2():S30-7. PubMed ID: 1940122 [Abstract] [Full Text] [Related]
28. [Clinical analysis of the effectiveness and safety of vigabatrin]. Jedrzejczak J, Owczarek K. Neurol Neurochir Pol; 2000 Sep 10; 34 Suppl 1():177-85. PubMed ID: 10768157 [Abstract] [Full Text] [Related]
29. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability. Ylinen A. J Intellect Disabil Res; 1998 Dec 10; 42 Suppl 1():46-9. PubMed ID: 10030432 [Abstract] [Full Text] [Related]
30. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study]. Kozik A, Ujma-Czapska B, Grotowska M. Neurol Neurochir Pol; 2000 Dec 10; 34 Suppl 1():187-93. PubMed ID: 10768158 [Abstract] [Full Text] [Related]
31. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients]. López-Valdés E, Hernández-Laín A, Simón R, Porta J, Mateos F. Rev Neurol; 1996 Oct 10; 24(134):1255-7. PubMed ID: 8983724 [Abstract] [Full Text] [Related]
32. [In children with refractory epilepsy: vigabatrin or lamotrigine?]. Caviedes BE, Herranz JL, Arteaga R, Armijo JA. Rev Neurol; 1996 Oct 10; 28(5):444-8. PubMed ID: 10229954 [Abstract] [Full Text] [Related]
33. Long-term follow-up study of vigabatrin in pretreated children with West syndrome. Siemes H, Brandl U, Spohr HL, Völger S, Weschke B. Seizure; 1998 Aug 10; 7(4):293-7. PubMed ID: 9733404 [Abstract] [Full Text] [Related]
34. Psychotic and severe behavioural reactions with vigabatrin: a review. Ferrie CD, Robinson RO, Panayiotopoulos CP. Acta Neurol Scand; 1996 Jan 10; 93(1):1-8. PubMed ID: 8825264 [Abstract] [Full Text] [Related]
35. Vigabatrin in intractable childhood epilepsy: a retrospective study. Gibbs JM, Appleton RE, Rosenbloom L. Pediatr Neurol; 1992 Jan 10; 8(5):338-40. PubMed ID: 1418176 [Abstract] [Full Text] [Related]
36. Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood. Dimova PS, Korinthenberg R. Pediatr Neurol; 1999 Nov 10; 21(5):802-7. PubMed ID: 10593670 [Abstract] [Full Text] [Related]
37. Aminoaciduria resulting from vigabatrin administration in children with epilepsy. Lahat E, Ben-Zeev B, Zlotnik J, Sela BA. Pediatr Neurol; 1999 Jul 10; 21(1):460-3. PubMed ID: 10428431 [Abstract] [Full Text] [Related]
38. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN, Sander JW. Drug Saf; 1994 Jul 10; 11(1):37-67. PubMed ID: 7917080 [Abstract] [Full Text] [Related]
39. Dose-response study of vigabatrin in children with refractory epilepsy. Herranz JL, Arteaga R, Farr IN, Valdizan E, Beaumont D, Armijo JA. J Child Neurol; 1991 Jul 10; Suppl 2():S45-51. PubMed ID: 1940124 [Abstract] [Full Text] [Related]
40. Rationalized polytherapy for epilepsy. Goldsmith P, de Bittencourt PR. Acta Neurol Scand Suppl; 1995 Jul 10; 162():35-9. PubMed ID: 7495188 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]